Non-pharmacological treatment in asthma and COPD

Andre Nybeg (Sweden)

Source: ERS Course 2019 - Masterclass in airways disease 2019
Number: 11
Disease area: Airway diseases

Slide presentationWebcast

Rating: 4.5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Andre Nybeg (Sweden). Non-pharmacological treatment in asthma and COPD. ERS Course 2019 - Masterclass in airways disease 2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Saeed Boroujeni Vahedi - 05.04.2020 12:02
Thank you for sharing! I enjoyed it a lot. Just missed more spesific exercise training plan for COPD patient, who can not be refered to a center for rehabilitation.
You must Login to comment this presentation.

Related content which might interest you:
Pharmacologic treatment of exacerbations of COPD
Source: International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline
Year: 2016

Pharmacological strategies for self-management of asthma exacerbations
Source: Eur Respir J 2006; 28: 182-199
Year: 2006

Recommendations for pharmacological treatment of exacerbations of COPD
Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Year: 2017

Bronchodilator treatment for asthma and COPD
Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD
Year: 2010

Therapeutic options for COPD exacerbations
Source: International Congress 2014 – PG04 Update on COPD exacerbations
Year: 2014

Non-pharmacological management of dyspnoea and cough in COPD
Source: International Congress 2014 – Primary Care Programme "Management of COPD and other respiratory conditions in clinical practice"
Year: 2014

Acute severe asthma: evidence-based management of asthma exacerbations
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008

Refining asthma treatment for mild asthma
Source: Virtual Congress 2020 – Rethinking asthma
Year: 2020

Exacerbations of asthma and treatment
Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2018

Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013

The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013

Combination asthma medication and healthcare use in severe or difficult-to-treat asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004

Comorbidities – should we and how should we treat them in asthma and COPD?
Source: International Congress 2014 – PG02 Current clinical problems in pulmonology
Year: 2014

The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016

The use of omalizumab in the management of severe chronic paediatric asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008

Macrolides in the prevention of COPD exacerbations
Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Year: 2012

Self-management in asthma patients
Source: International Congress 2017 – PG21 Self-management in chronic respiratory diseases
Year: 2017